Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 82 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company 3i-Nano | Activity: Research and Development | Company Description 3i Nano develops point-of-care devices for disease diagnostics and protein detection. Potential applications include cardiac, sepsis, meningitis, and respiratory. | Location Greensboro |
| |
Company Accord Healthcare Inc. | Activity: Sales and Operations | Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. | Location Durham |
| |
Company Aerami Therapeutics | Activity: Research and Development | Company Description Aerami Therapeutics develops soft mist inhaled formulations of biologics and inhalation devices to treat severe and chronic diseases. Its first product is for the treatment of diabetes. | Location Durham |
| |
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops peptide-based technologies, including diagnostic products, research tools and therapeutic drug monitoring products for use by clinicians and researchers. | Location Durham |
| |
Company Amgen | Activity: Production and Manufacturing | Company Description Amgen will manufacture therapeutics for cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The site is expected to be operational by 2025. | Location Apex |
| |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Research Triangle Park |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Baebies Inc. | Activity: Production and Manufacturing | Company Description Baebies is a medical device company that develops and commercializes products to enable early disease detection and comprehensive diagnosis for children and adults. | Location Durham |
| |
Company Basking Biosciences Inc. | Activity: Research and Development | Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. | Location Research Triangle Park |
| |
Company Bio 54 LLC | Activity: Research and Development | Company Description Bio 54 is developing a hand-held drug delivery device for patients to treat external bleeding from minor wounds in anticoagulant patients. | Location Chapel Hill |
| |
Company Caidya | Activity: Contract Research and Testing | Company Description Caidya provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease. | Location Morrisville |
| |
Company CardioPharma Inc. | Activity: Research and Development | Company Description CardioPharma develops combinatorial products to treat cardiovascular disease. | Location Wilmington |
| |
Company Charles River Laboratories (Durham) | Activity: Contract Research and Testing | Company Description Charles River Laboratories' Oncology Center of Excellence provides in vivo and in vitro oncology and immuno-oncology research services. | Location Durham |
| |
Company Chiesi USA Inc. | Activity: Research and Development | Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. | Location Cary |
| |
Company CMP Pharma Inc. | Activity: Production and Manufacturing | Company Description CMP develops, manufactures and commercializes niche oral liquid medications that address the needs of patients with difficulty swallowing solid dosage forms. | Location Farmville |
| |
Company Contego Medical LLC | Activity: Research and Development | Company Description Contego Medical develops embolic protection devices for cardiovascular and peripheral vascular procedures, designed to simplify catheter-based procedures. | Location Raleigh |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company Grifols (RTP) | Activity: Sales and Operations | Company Description Grifols manufactures and markets plasma-derived medicines to treat chronic and acute conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. | Location Research Triangle Park |
| |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham |
| |
Company InnAVasc Medical Inc. | Activity: Research and Development | Company Description InnAVasc Medical designs and develops products for vascular access. The company's first technology is an arteriovenous graft (AVG) modification that facilitates graft access and safety in hemodialysis. | Location Durham |
| |
Company Kowa Research Institute Inc. | Activity: Research and Development | Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. | Location Morrisville |
| |
Company Liquidia Corporation | Activity: Research and Development | Company Description Liquidia Corporation develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension (PAH) and other applications using its proprietary particle engineering technology. | Location Morrisville |
| |
Company MD Scientific LLC | Activity: Research and Development | Company Description MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents. | Location Charlotte |
| |
Company Milestone Pharmaceuticals USA Inc. | Activity: Research and Development | Company Description Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions. | Location Charlotte |
| |
Company Momentum Research Inc. | Activity: Contract Research and Testing | Company Description Momentum Research manages and directs phase one through four clinical research projects and specializes in cardiovascular clinical trials management. | Location Durham |